Alnylam Pharmaceuticals News

Alnylam to Webcast Presentation at Deutsche Bank 38th Annual dbAccess Health Care Conference

Business Wire May 21

Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, today announced that management will present a company overview at the Deutsche Bank 38th Annual dbAccess Health Care Conference on Wednesday, May 29, 2013 at 2:50 p.m.

Alnylam announces proof-of-concept data from RNAi program

May 17

Alnylam (ALNY) Updates on Preclinical Data for RNAi Program Targeting ALAS-1

Street Insider May 17

InPlay: Alnylam Pharma presents key pre-clinical proof-of-concept data for ALN-AS1; RNAi therapeutics targeting ALAS-1 completely block production of toxic heme biosynthesis intermediates that cause symptoms and disease pathology

May 17

Alnylam Presents Key Pre-Clinical Proof-of-Concept Data for ALN-AS1, an RNAi Therapeutic Targeting Aminolevulinate Synthase-1 (ALAS-1) for the Treatment of Porphyria

Business Wire May 17

Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, announced today that it has presented key pre-clinical proof-of-concept data from its RNAi therapeutic program targeting aminolevulinate synthase-1 for the treatment of porphyria including acute intermittent porphyria .

Alnylam Pharmaceuticals' CEO Presents at 2013 Bank of America Merrill Lynch Health Care Conference (Transcript)

Seeking Alpha May 16

Alnylam Pharmaceuticals' CEO Presents at 2013 Bank of America Merrill Lynch Health Care Conference (Transcript)

Alnylam to Webcast Presentation at 2013 UBS Global Healthcare Conference

Business Wire May 15

Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, today announced that management will present a company overview at the 2013 UBS Global Healthcare Conference on Wednesday, May 22, 2013 at 8:00 a.m.

Zacks #1 Rank Additions for Thursday - Tale of the Tape

Zacks May 9

Here are 5 stocks added to the Zacks #1 Rank ("strong buy") List for Thursday

Alnylam to Webcast Presentation at 2013 Bank of America Merrill Lynch Health Care Conference

Business Wire May 8

Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, today announced that management will present a company overview at the 2013 Bank of America Merrill Lynch Health Care Conference on Thursday, May 16, 2013 at 8:40 a.m.